These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 29137651)
21. Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3. Reinders NR; Pao Y; Renner MC; da Silva-Matos CM; Lodder TR; Malinow R; Kessels HW Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6526-E6534. PubMed ID: 27708157 [TBL] [Abstract][Full Text] [Related]
22. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease. Bories C; Arsenault D; Lemire M; Tremblay C; De Koninck Y; Calon F Aging (Albany NY); 2017 May; 9(5):1386-1403. PubMed ID: 28522792 [TBL] [Abstract][Full Text] [Related]
23. Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model. Smith LA; McMahon LL Neurobiol Dis; 2018 Feb; 110():166-179. PubMed ID: 29199135 [TBL] [Abstract][Full Text] [Related]
24. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
25. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease. Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830 [TBL] [Abstract][Full Text] [Related]
26. Maternal Loss of Ube3a Impairs Experience-Driven Dendritic Spine Maintenance in the Developing Visual Cortex. Kim H; Kunz PA; Mooney R; Philpot BD; Smith SL J Neurosci; 2016 Apr; 36(17):4888-94. PubMed ID: 27122043 [TBL] [Abstract][Full Text] [Related]
28. Calcium signaling, excitability, and synaptic plasticity defects in a mouse model of Alzheimer's disease. Zhang H; Liu J; Sun S; Pchitskaya E; Popugaeva E; Bezprozvanny I J Alzheimers Dis; 2015; 45(2):561-80. PubMed ID: 25589721 [TBL] [Abstract][Full Text] [Related]
29. Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment. Zhang H; Sun S; Wu L; Pchitskaya E; Zakharova O; Fon Tacer K; Bezprozvanny I J Neurosci; 2016 Nov; 36(47):11837-11850. PubMed ID: 27881772 [TBL] [Abstract][Full Text] [Related]
30. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768 [TBL] [Abstract][Full Text] [Related]
31. Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease. Heiss JK; Barrett J; Yu Z; Haas LT; Kostylev MA; Strittmatter SM Cereb Cortex; 2017 Jul; 27(7):3660-3674. PubMed ID: 27365298 [TBL] [Abstract][Full Text] [Related]
32. Multibranch activity in basal and tuft dendrites during firing of layer 5 cortical neurons in vivo. Hill DN; Varga Z; Jia H; Sakmann B; Konnerth A Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13618-23. PubMed ID: 23904480 [TBL] [Abstract][Full Text] [Related]
33. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596 [TBL] [Abstract][Full Text] [Related]
34. Effects of curcumin on synapses in APPswe/PS1dE9 mice. He Y; Wang P; Wei P; Feng H; Ren Y; Yang J; Rao Y; Shi J; Tian J Int J Immunopathol Pharmacol; 2016 Jun; 29(2):217-25. PubMed ID: 26957323 [TBL] [Abstract][Full Text] [Related]
35. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease. Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172 [TBL] [Abstract][Full Text] [Related]
37. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Knobloch M; Mansuy IM Mol Neurobiol; 2008 Feb; 37(1):73-82. PubMed ID: 18438727 [TBL] [Abstract][Full Text] [Related]
38. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686 [TBL] [Abstract][Full Text] [Related]
39. Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau. Dickstein DL; Brautigam H; Stockton SD; Schmeidler J; Hof PR Brain Struct Funct; 2010 Mar; 214(2-3):161-79. PubMed ID: 20213269 [TBL] [Abstract][Full Text] [Related]
40. Vulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis. Verdaguer E; Brox S; Petrov D; Olloquequi J; Romero R; de Lemos ML; Camins A; Auladell C Exp Gerontol; 2015 Sep; 69():176-88. PubMed ID: 26099796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]